Sarepta Therapeutics (SRPT) Earnings Call Presentation

Patients can't wait for the next breakthrough in medical research. An ELEVIDYS Safety Update in Non-Ambulatory Patients So neither will we. Doug Ingram President & CEO Louise Rodino-Klapac, PhD Executive Vice President, Head of R&D, Chief Scientific Officer June 16, 2025 ©SAREPTA THERAPEUTICS, INC. 2025. ALL RIGHTS RESERVED. 1 DILLON Living with Duchenne muscular dystrophy Doug Ingram ©SAREPTA THERAPEUTICS, INC. 2025. ALL RIGHTS RESERVED. 2 Forward-looking statements This presentation contains "forward-look ...